8-K
Current Report
X4 Pharmaceuticals, Inc Filed Acc 0001193125-19-061101
Agreement ended · Other events
- Item 1.02 Termination of a material definitive agreement
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading d704032d8k.htm…